Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Shares Outstanding (Diluted Average): 2022-2024

Historic Shares Outstanding (Diluted Average) for Insight Molecular Diagnostics (IMDX) over the last 3 years, with Dec 2024 value amounting to $13.1 million.

  • Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) rose 133.58% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year increase of 133.58%. This contributed to the annual value of $13.1 million for FY2024, which is 70.84% up from last year.
  • As of FY2024, Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) stood at $13.1 million, which was up 70.84% from $7.7 million recorded in FY2023.
  • Over the past 5 years, Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) peaked at $13.1 million during FY2024, and registered a low of $5.5 million during FY2022.
  • In the last 3 years, Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) had a median value of $7.7 million in 2023 and averaged $8.8 million.
  • Data for Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 70.84% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Insight Molecular Diagnostics' Shares Outstanding (Diluted Average) stood at $5.5 million in 2022, then spiked by 38.10% to $7.7 million in 2023, then spiked by 70.84% to $13.1 million in 2024.